An elevated neutrophil-to-lymphocyte ratio predicts a poor postoperative survival in primary hepatocellular carcinoma patients with a normal preoperative serum level of alpha-fetoprotein

Purpose Although alpha-fetoprotein (AFP) is a useful prognostic marker in patients with hepatocellular carcinoma (HCC), a recent study has shown that the preoperative neutrophil-to-lymphocyte ratio (NLR) is also associated with the postoperative survival in such patients. Objective To investigate th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery today (Tokyo, Japan) Japan), 2019-08, Vol.49 (8), p.661-669
Hauptverfasser: Shiraki, Takayuki, Ishizuka, Mitsuru, Kubota, Keiichi, Kato, Masato, Matsumoto, Takatsugu, Mori, Shozo, Shimizu, Takayuki, Aoki, Taku
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Although alpha-fetoprotein (AFP) is a useful prognostic marker in patients with hepatocellular carcinoma (HCC), a recent study has shown that the preoperative neutrophil-to-lymphocyte ratio (NLR) is also associated with the postoperative survival in such patients. Objective To investigate the significance of the NLR in patients with primary HCC (p-HCC) showing a normal preoperative AFP. Methods Among 478 p-HCC patients undergoing curative surgery, 112 who had a normal AFP ( 3.2). Uni- and multivariate analyses were performed to compare clinical features with the overall survival (OS). Results A multivariate analysis of the clinical features showed that the NLR (> 3.2/≤ 3.2) (hazard ratio 2.366; 95% CI 1.069–5.235; P  = 0.034) was closely associated with the OS, along with the age (> 65/≤ 65 years) ( P  = 0.033). Group B had a significantly lower survival ratio than group A in terms of not only the OS ( P  = 0.013), but also the cancer-specific survival ( P  = 0.002) and relapse-free survival ( P  = 0.039). Conclusions An elevated NLR (> 3.2) is predictive of a poor survival in patients with primary HCC (p-HCC) showing normal AFP levels.
ISSN:0941-1291
1436-2813
DOI:10.1007/s00595-019-01781-1